Kevin Lee (Kwanghee Lee)

Kevin Lee is a Director and has been focused on investments in the areas of biotechnology and investment technology. He has led approximately USD 80 million in investments in 42 companies of which 18 companies successfully held on a variety of exchanges such as KSE, KOSDAQ, and NASDAQ.  His investments include US and Korea companies. He has served as a director with Standard Diagnostic, Inc (KOSDAQ) for three years.  He then became the CEO and Director for Sudopham. Ind. Co., Ltd (KSE) for a year.  He is currently involved with the management of Cintel Corp (Non-NASDAQ OTCBB) as a secretary and treasurer (director). Prior to KTB Investments, Kevin had been an assistant manager of a marketing team at Hanmi Capital Corp. He received an MBA from Hanyang University, and a BS in Business Administration from Seogang University. Kevin has completed the Advance Management Program, Cyber AMP and TTMP. He is an  experienced Instructor at Venture Capital Academy Program and Technopark Venture Program.